TABLE 3

Location of Lesions Identified by ¹¹¹In-DTPA-Octreotide Scintigraphy, ⁶⁸Ga-DOTATATE PET, and Cross-Sectional Imaging (CT ± MRI) in 47 Patients with Radiologic Evidence of Disease

Organ or region	¹¹¹In-DTPA-octreotide scintigraphy	⁶⁸Ga-DOTATATE PET	P^*	CT ± MRI
Lung	3	9	0.001	16
Breast	0	1	NS	1
Pancreas	4	6	NS	6
Liver	6	23	<0.001	34
Gastrointestinal tract	0	7	<0.001	7
Kidney	2	3	NS	2
Spleen	0	0	NS	1
Pelvis or ovaries	2	1	NS	1
Thoracic nodes	0	17	<0.001	17
Mesenteric nodes	1	19	<0.001	37
Abdominal nodes	9	27	<0.001	45
Vertebrae	0	19	<0.001	23
Bones	0	36	<0.001	36
Total	27	168	<0.001	226

↵* To determine whether a significant difference was present in number of lesions identified using ⁶⁸Ga-DOTATATE PET and ¹¹¹In-DTPA-octreotide scintigraphy, P > 0.05 was regarded as nonsignificant (NS).